135 related articles for article (PubMed ID: 33978904)
1. Progressive multifocal leukoencephalopathy and Creutzfeldt-Jakob disease: population-wide incidences, comorbidities, costs of care, and outcomes.
Bakal JA; Charlton CL; Hlavay B; Jansen GH; Svenson LW; Power C
J Neurovirol; 2021 Jun; 27(3):476-481. PubMed ID: 33978904
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989.
Gillespie SM; Chang Y; Lemp G; Arthur R; Buchbinder S; Steimle A; Baumgartner J; Rando T; Neal D; Rutherford G
Ann Neurol; 1991 Oct; 30(4):597-604. PubMed ID: 1665053
[TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leukoencephalopathy.
Zhai S; Brew BJ
Handb Clin Neurol; 2018; 152():123-137. PubMed ID: 29604971
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy deaths in the USA, 1979-2005.
Christensen KL; Holman RC; Hammett TA; Belay ED; Schonberger LB
Neuroepidemiology; 2010; 35(3):178-84. PubMed ID: 20664291
[TBL] [Abstract][Full Text] [Related]
5. Multifocal necrotizing leukoencephalopathy mimicking sporadic Creutzfeldt-Jakob disease.
Imperiale D; Taraglio S; Atzori C; Testi R; Buffa C; Migheli A
Eur Neurol; 2008; 59(6):327-9. PubMed ID: 18408376
[No Abstract] [Full Text] [Related]
6. Progressive multifocal leukoencephalopathy: A 25-year retrospective cohort study.
Anand P; Hotan GC; Vogel A; Venna N; Mateen FJ
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31554669
[TBL] [Abstract][Full Text] [Related]
7. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
8. Mortality trend from sporadic Creutzfeldt-Jakob disease (CJD) in Italy, 1993-2000.
Puopolo M; Ladogana A; Almonti S; Daude N; Bevivino S; Petraroli R; Poleggi A; Quanguo L; Pocchiari M
J Clin Epidemiol; 2003 May; 56(5):494-9. PubMed ID: 12812825
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program.
Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S
Prion; 2015; 9(2):136-43. PubMed ID: 25996401
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of Creutzfeldt-Jakob disease in Italy (1972-1986).
Masullo C; Pocchiari M; Neri G; Casaccia P; Iavarone A; Ladogana A; Macchi G
Eur J Epidemiol; 1988 Dec; 4(4):482-7. PubMed ID: 3060369
[TBL] [Abstract][Full Text] [Related]
11. [Slow virus infection: the Japanese clinical statistical data].
Takasu T; Nishimura T
Nihon Rinsho; 1992 Nov; 50 Suppl():77-93. PubMed ID: 1344418
[No Abstract] [Full Text] [Related]
12. Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era.
Casado JL; Corral I; García J; Martinez-San Millán J; Navas E; Moreno A; Moreno S
Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):179-87. PubMed ID: 23948752
[TBL] [Abstract][Full Text] [Related]
13. Creutzfeldt-Jakob disease in the elderly.
de Silva R; Findlay C; Awad I; Harries-Jones R; Knight R; Will R
Postgrad Med J; 1997 Sep; 73(863):557-9. PubMed ID: 9373595
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data.
Holman RC; Janssen RS; Buehler JW; Zelasky MT; Hooper WC
Neurology; 1991 Nov; 41(11):1733-6. PubMed ID: 1944901
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population.
Eng PM; Turnbull BR; Cook SF; Davidson JE; Kurth T; Seeger JD
Neurology; 2006 Sep; 67(5):884-6. PubMed ID: 16966559
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan.
Nakamichi K; Mizusawa H; Yamada M; Kishida S; Miura Y; Shimokawa T; Takasaki T; Lim CK; Kurane I; Saijo M
BMC Neurol; 2012 Oct; 12():121. PubMed ID: 23066763
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
[TBL] [Abstract][Full Text] [Related]
18. Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study.
Sipilä JOT; Soilu-Hänninen M; Rautava P; Kytö V
J Neurol; 2019 Feb; 266(2):515-521. PubMed ID: 30612143
[TBL] [Abstract][Full Text] [Related]
19. Creutzfeldt-Jakob Disease in South West Sydney 2014-2020: An Unusually High Incidence of a Rare Disease.
Goire N; Edwards L; Thomas P; Bhaskar SMM; Cordato D; Buckland ME; Beran RG
Neuroepidemiology; 2022; 56(1):59-65. PubMed ID: 34763340
[TBL] [Abstract][Full Text] [Related]
20. Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt-Jakob disease and multiple sclerosis.
Lai CH; Tseng HF
Neuroepidemiology; 2009; 33(3):247-53. PubMed ID: 19641330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
